UPC: life sciences lead the momentum at new court

On June 1, 2023, the Unified Patent Court (UPC) opened its doors for business. This marked an important milestone in European patent jurisdiction. It provides a new venue for parties in cross-jurisdictional patent disputes.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

UPC judge and Regeneron counsel urge lobbying to improve court's transparency

23 November 2023 Judge encourages lawyers and public to make their voices heard over transparency concerns | Awkward access to public hearings ‘causing problems’ says Regeneron counsel | Plea for public virtual hearings as judge notes that requests have been ‘coming in by the dozen’ | Panellists discuss at LSPN Europe.

Big Pharma

‘A huge shame’: UPC denies access to pleadings and evidence in Sanofi v Amgen

26 September 2023 An updated UPC rule requires a concrete and verifiable, legitimate reason for making available written pleadings and evidence | The wish from a natural person to form an opinion on the validity of a patent deemed insufficient reason for access | First decision marks latest twist in Amgen v Sanofi showdown.

Big Pharma

UPC after one month: Life sciences cases

29 June 2023 Revocation and infringement actions involving a cholesterol treatment, prosthetic valves, and methods for analyte detection are among the first to land at the court within its first month, explain Joanne Welch and Darren Smyth of EIP.